Table of Contents
Unit I - Basic Concepts in Pharmacology
Chapter 1 - Introduction to Pharmacology; Drug Regulation and Approval
Chapter 2 - Drug Classes, Schedules and Categories
Chapter 3 - Methods of Drug Administration
Chapter 4 - What Happens After a Drug Has Been Administered
Chapter 5 — Herbs and Dietary Supplements
Chapter 6 - Substance Abuse
Unit II — The Nervous System
Chapter 7 — Drugs Affecting Functions of the Autonomic Nervous System
Chapter 8 - Drugs for Anxiety and Insomnia
Chapter 9 - Drugs for Emotional and Mood Disorders
Chapter 10 - Drugs for Psychoses and Degenerative Diseases of the Nervous System
Chapter 11 - Drugs for Seizures
Chapter 12 - Drugs for Pain Control
Chapter 13 — Drugs for Anesthesia
Unit III — The Cardiovascular System
Chapter 14 - Drugs for Coagulation Disorders
Chapter 15 — Drugs for Hypertension
Chapter 16 - Drugs for Heart Failure
Chapter 17 — Drugs for Dysrhythmias
Chapter 18 - Drugs for Angina Pectoris, Myocardial Infarction, and Cerebrovascular Accident
Chapter 19 - Drugs for Shock and Anaphylaxis
Chapter 20 — Drugs for Lipid Disorders
Unit IV — The Immune System
Chapter 21 - Drugs for Inflammation, Allergies, and Immune Disorders
Chapter 22 - Drugs for Bacterial Infections
Chapter 23 - Drugs for Fungal, Viral, and Parasitic Infections
Chapter 24 — Drugs for Neoplasia
Unit V — The Respiratory, Digestive, and Renal Systems
Chapter 25 - Drugs for Pulmonary Disorders
Chapter 26 - Drugs for Gastrointestinal Disorders
Chapter 27 — Vitamins, Minerals, and Nutritional Supplements
Chapter 28 - Drugs for Fluid, Acid-Base, and Electrolyte Disorders
Unit VI — The Endocrine and Reproductive Systems
Chapter 29 - Drugs for Endocrine Disorders
Chapter 30 — Drugs for Disorders and Conditions of the Reproductive System
Unit VII — The Musculoskeletal System, Integumentary System, and Eyes and Ears
Chapter 31 - Drugs for Muscle, Bone, and Joint Disorders
Chapter 32 — Drugs for Skin Disorders
Chapter 33 — Drugs for Eye and Ear Disorders
Appendix A: References
Appendix B: Answers to NCLEX-PNÔ and Case Study Questions
Appendix C: Top 200 Drugs
Index